• LinkedIn
  • Google +
  • Twitter
  • Facebook

+1-571-223-6845

Bid Protest Weekly
  • Home
  • Bid Protest Ed Center
    • WHAT is a bid protest?
    • WHO can file a bid protest
    • DO I need an Attorney?
    • WHY Should you file a bid protest?
    • WHEN Must you file a bid protest?
    • WHERE can you file a bid protest?
    • READING the RFP
  • Blog
  • Topics
  • About Us
  • Contact Us

Panacea Biotec, Inc., B-400776, January 21, 2009

  • By GCPC GovCon Legal Team
  • January 21, 2009
  • Competitive RangePast Performance

Link: GAO Opinion

Agency: Department of Health and Human Services

Disposition: Protest denied.

__________________________________________________________________________________________________________________

GAO Digest:

Agency reasonably excluded the protester’s proposal from the competitive range, where the agency reasonably determined that the protester’s proposal contained major and significant weaknesses and deficiencies, such that the proposal was found to be unacceptable, would require major revisions to be made acceptable, and was significantly lower rated than the proposals included in the competitive range.

General Counsel P.C. Highlight:

Panacea generally challenges the agency’s exclusion of its proposal from the competitive range, arguing that the agency’s technical evaluation reflected bias in favor of those firms (offerors A and B) that had proposed an rPA anthrax vaccine developed through grants from the United States government and against Panacea, which had developed its vaccine at private expense in a foreign country. In this regard, Panacea argues that some of the evaluated major and significant weaknesses and deficiencies in its technical proposal reflect the agency’s bias. GAO finds no basis from its review of the record to conclude that the evaluation of Panacea’s proposal and its exclusion from the competitive range was the result of HHS favoring firms that had earlier received funding or was otherwise motivated by bias or bad faith on the part of HHS. In this regard, government officials are presumed to act in good faith, and GAO will not attribute unfair or prejudicial motives to procurement officials on the basis of inference or supposition.

Panacea first complains that the TEP chairperson’s evaluation summary of Panacea’s proposal under the technical merit/time line subfactor incorrectly stated that the protester had not produced bulk drug substance (BDS) of its anthrax vaccine. The protester contends that it has produced BDS at quantities as large as “[DELETED] pilot scale batches.” With respect to Panacea’s challenge to the reasonableness of some of weaknesses and deficiencies evaluated in its proposal, GAO states that it will review an agency’s evaluation and exclusion of a proposal from the competitive range for reasonableness and consistency with the solicitation criteria and applicable statutes and regulations. Contracting agencies are not required to retain in the competitive range proposals that are not among the most highly rated or that the agency otherwise reasonably concludes have no realistic prospect of being selected for award.

The agency states that the TEP recognized that Panacea had done BDS process development on a small scale and that the weakness assessed in Panacea’s proposal was that Panacea had not produced BDS of its proposed vaccine at a scale required for the contract. This contention is supported by the contemporaneous evaluation record. The protester responds, however, that there is “no mandatory requirement” in the solicitation for BDS production on a commercial scale and that therefore downgrading Panacea’s proposal for failing to show BDS production at this scale was unreasonable. GAO finds this argument to be without merit, however, given that the RFP informed offerors that the agency would be evaluating under the technical approach subfactor whether the “[c]ontractor has demonstrated validated bulk drug substance (BDS) production at proposed commercial scale.”

The protester also complains that its proposal should not have been downgraded for a lack of FDA experience. HHS downgraded Panacea’s proposal because the firm had failed to demonstrate experience with, or for that matter good understanding of, the FDA and that agency’s regulatory process. In this regard, the RFP informed offerors that contractors would be required to satisfy FDA requirements for “potential use of the vaccine in a [post-exposure prophylaxis] plus antibiotic scenario in a declared emergency under an EUA” and to otherwise obtain licensing in accordance with FDA regulations, and offerors were informed that the experience of their personnel to perform the contract would be evaluated. The agency states that it did not credit Panacea for the FDA experience of its subcontractors because Panacea’s proposal identified Panacea, and not the subcontractors, as being responsible for dealing with the FDA. GAO has no basis to object to this determination, given that Panacea’s proposal did not identify any subcontractors to be members of its “regulatory team,” which Panacea stated would deal with the FDA and be responsible for regulatory submissions.

Panacea also disagrees with the TEP’s finding that Panacea had not demonstrated “an understanding of the relationship of the animal models, human clinical data and correlates of protection.” HHS responds that, while Panacea provided some information in its proposal regarding historical and proposed non-clinical studies and for proposed clinical studies, the firm did not explain its studies in a way that showed how the studies would “contribute to the body of knowledge required to conclusively demonstrate a correlate of protection and efficacy of the product.” HHS also states that Panacea’s descriptions of its non-clinical studies and clinical studies did not show that it incorporated suggestions and recommendations of the FDA. Panacea does not show that the agency’s evaluation in this regard was unreasonable. Rather, in its comments, Panacea merely objects to two statements in the agency’s legal memorandum with respect to whether Panacea provided “passive transfer studies” in its proposal and whether Panacea’s proposal provided for studies of the vaccine at various dosages. Neither of these two concerns, however, shows that the agency’s overall criticism that Panacea had failed to demonstrate an understanding of the relationship of the animal models, human clinical data, and correlates of protection was unreasonable.

Finally, in its comments on the agency’s report, Panacea raises numerous new challenges to the agency’s evaluation. Specifically, Panacea objects to HHS’s “mechanical reliance on point scores,” that standards were allegedly not established for assigning point scores, and that the assigned point scores were not adequately supported by the TEP’s narrative discussion. GAO finds that these supplemental grounds of protest were not timely filed. The protest is denied.

Share

Related Posts

Matter of Science Applications International Corporation

February 28, 2022

Competitive Range – Matter of: Pinnacle Solutions, Inc.

August 25, 2017

Silverback7, Inc., B-408053.2; B-408053.3, August 26, 2013

October 9, 2013

Global Technology Systems, Inc., B-408461, August 30, 2013

September 10, 2013

Comments are closed

Search Bid Protest Weekly

Need help with a bid protest?

Call us at: 703-556-0411 Or fill out this form:

Categories

  • 8(a) Sole Source Awards
  • Acknowledging Amendments
  • Adequately Written Proposal
  • Adverse Agency Action
  • Adverse Impact Analysis
  • Agency Tender
  • Alternate or Previously-Approved Product
  • Ambiguity in Solicitation
  • Attorney's Fees
  • Bad Faith in Evaluation
  • Below-Cost Offer
  • Best Value
  • Beyond the Scope
  • Bias
  • Bid and Proposal Costs
  • Bid Bond
  • Bid Compliance
  • Bid Protest Decisions
  • Bid Protest Jurisdiction
  • Bid Protests
  • Bidding Best Practices
  • Blanket Purchase Agreement
  • Blanket Purchase Order
  • Blog Articles
  • Bona Fide Needs Rule
  • Brand Name or Equal
  • Broad Agency Announcement
  • Brooks Act
  • Bundling or Consolidation
  • Buy American Act
  • Cancellation of a Solicitation
  • Capability of Contractor
  • CCR Registration
  • Certificate of Competency (COC)
  • Certification Requirements
  • Changes Clause
  • Clarifications
  • Clear and Convincing Evidence
  • Clearly Meritorious Protest
  • Clerical Error
  • Commercial Item Acquisition
  • Competitive Range
  • Compliance
  • Conflict of Interest
  • Construction Design-Build
  • Construction Services
  • Contract Administration
  • Contract Modifications
  • Contracting Preference
  • Contractor Responsibility
  • Corporate Capability
  • Corrective Action
  • Cost Accounting System
  • Cost Evaluation
  • Cost Realism
  • Cost Reimbursement Contract
  • Cost-Technical Trade-Off
  • Customary Commercial Practice
  • CVE
  • DCAA Audit
  • Debriefing
  • Default Termination
  • Deficient Price Proposal
  • Delivery Order jurisdiction
  • Delivery Schedule
  • Designated Employee Agent
  • Disclosure of Price
  • Disclosure of Source Selection-Sensitive Information
  • Discussions
  • Disqualification
  • Documentation of Evaluation
  • Domestic Production Requirement
  • Education Center Articles
  • Electronic Filing
  • Evaluation Criteria
  • Evaluations
  • Events
  • Executive Order Compliance
  • Experience of Contractor
  • Experience Requirement
  • Fair Market Price
  • FASA
  • FedBizOpps
  • Federal Prison Industries (FPI)
  • Filing Deadlines
  • Final Evaluation
  • Final Proposal Revisions
  • Financial Responsibility
  • Fixed Price Contract
  • Former Government Employees
  • FSS Contract
  • GAO Bid Protest Review
  • GAO Jurisdiction
  • GAO Standard of Review
  • Government Contracts
  • Government Office Closings
  • Government Surplus Material
  • GSA Lease
  • HUBZone
  • ID/IQ
  • In-Sourcing
  • Incentive Fee
  • Inclement Weather Delay
  • Incomplete Proposal
  • Incorporation by Reference
  • Incumbent Capture
  • Incumbent Status
  • Independent Government Estimate (IGE)
  • Individual Environmental Report
  • Industrial Mobilization
  • Innovations
  • Interested Party
  • Invitation for Bid
  • Invited Contractor
  • Javits-Wagner-O'Day Act
  • Joint Venture
  • Key Personnel
  • Labor Hours
  • Labor Rate Pricing
  • Late Proposals
  • Late Submissions
  • Level of Effort
  • Licensing Requirements
  • Limitation on Subcontracting
  • Liquidated Damages
  • Lost Proposal
  • Lowest Price Technically Acceptable
  • Mail-Box Rule
  • Management Planning
  • Market Research
  • MAS Contracts
  • Material Misrepresentation
  • Material Solicitation Amendment
  • Material Solicitation Terms
  • Meaningful Discussions
  • Micro-Purchase Threshold
  • Minimum Requirements
  • Misleading Discussions
  • Mistake
  • Mitigation Strategy
  • Multiple Awards
  • NAICS Code
  • National Security
  • Negotiation
  • News
  • Non-Procurement Instruments
  • Novations
  • Offeror Representations
  • OMB Circular A-76
  • Option Exercise
  • Oral Presentations
  • Organizational Conflict of Interest (OCI)
  • Page Limitations
  • Past Performance
  • Past Performance Information Retrieval System (PPIRS)
  • Performance Based Standards
  • Permits and Responsibilities
  • Personal Conflicts of Interest
  • Post-Award Changes to the Contract
  • Post-Protest Re-Evaluations
  • Practicable Alternative
  • Pre-Award Protest
  • Pre-award vs. Post-award Requirements
  • Pre-Qualification of Offerors
  • Pre-Solicitation Notice
  • Prejudice
  • Price Calculation Error
  • Price Calculation Error
  • Price Evaluation
  • Price of FSS Task Order Quote
  • Price Realism
  • Price Reasonableness
  • Price Reduction
  • Procurement Announcement
  • Procurement Integrity
  • Product Testing
  • Proposal Acceptance Period
  • Proposal Detail
  • Proposal Evaluation
  • Proposal Extension
  • Proposal Standards
  • Proposals
  • Protest Terms of Solicitation
  • Protester Comments
  • Public-Private Competition
  • Randolph-Sheppard Act (RSA)
  • Rate Tenders
  • Re-Certification of Size Status
  • Reconsideration
  • Reevaluation
  • Reevaluation Standards
  • Reimbursement of Protest Costs
  • Rejection of Proposal
  • Relaxation or Waiver of Requirement
  • Relevancy of Past Performance
  • Reliance on the Proposal
  • Remedies
  • Requirements Contract
  • Responsibility
  • Responsiveness
  • Restricted Competition
  • Resumes
  • Revision of Proposal
  • Revision of Proposals
  • Risk
  • Rule of Two
  • SBA Status protest
  • Scope of GAO Review
  • SDVOSB Set-Asides
  • Significant Issue Exception
  • Simplified Acquisition Procedures
  • Site Visit
  • Size Determination
  • Size Protest
  • Small Business Innovation Research (SBIR) Program
  • Small Business Set-Asides
  • Small Business Subcontracting Goals
  • Sole-Source Award
  • Solicitation Amendment
  • Solicitation Requirements
  • Source Approval
  • Source Selection Authority
  • Source Selection Decision
  • Source Selection Plan
  • Sources Sought Notice
  • Staffing Plan
  • State and Local Requirements
  • Status of Forces Agreement (SOFA)
  • Subcontract Protest
  • Subcontractor Experience
  • Suspension and Debarment
  • Taking Exception to RFP Requirements
  • Task Orders
  • Teaming Agreement
  • Technical Acceptability
  • Technical Evaluation
  • Technical Evaluation
  • Termination of Award
  • Terms of the Solicitation
  • Timeliness of Protest
  • Timely Filing
  • Timely Performance
  • Timely Proposal Submission
  • Trade Agreement Act
  • Unbalanced Pricing
  • Unduly Restrictive Terms
  • Unequal Access to Information
  • Unequal Treatment of Offerors
  • Uniform Time Act of 1996
  • Unstated Evaluation Criteria
  • Unusual and Compelling Urgency
  • Use of Appropriated Funds
  • Veterans First
  • VIP Database
  • VOSB Set Asides
  • Wage Determination

Get Help


Talk to an
attorney who
specializes
in bid protests:

+1-571-223-6845
Email

Keep up to date
on bid protest
decisions and
policies:

© 2022 Bid Protest Weekly

  • LinkedIn
  • Google +
  • Twitter
  • Facebook
  • Home
  • Bid Protest Ed Center
  • Blog
  • Topics
  • About Us
  • Contact Us
  • Home
  • Bid Protest Ed Center
    • WHAT is a bid protest?
    • WHO can file a bid protest
    • DO I need an Attorney?
    • WHY Should you file a bid protest?
    • WHEN Must you file a bid protest?
    • WHERE can you file a bid protest?
    • READING the RFP
  • Blog
  • Topics
  • About Us
  • Contact Us
  • LinkedIn
  • Google +
  • Twitter
  • Facebook

+1-571-223-6845